Ventricular Assist Devices for Destination Therapy

Author(s):  
Sanjeev Aggarwal ◽  
Mark S. Slaughter
ASAIO Journal ◽  
2012 ◽  
Vol 58 (4) ◽  
pp. 396-401 ◽  
Author(s):  
Geetha Bhat ◽  
Shivani Kumar ◽  
Ashim Aggarwal ◽  
Sunil Pauwaa ◽  
German Rossell ◽  
...  

2005 ◽  
Vol 129 (1) ◽  
pp. 9-17 ◽  
Author(s):  
Soon J. Park ◽  
Alfred Tector ◽  
William Piccioni ◽  
Edward Raines ◽  
Annetine Gelijns ◽  
...  

2017 ◽  
Vol 103 (2) ◽  
pp. e179-e181 ◽  
Author(s):  
Ophelie Loup ◽  
Kerstin Wustmann ◽  
Michele Vittorio Martinelli ◽  
Markus Schwerzmann ◽  
Paul Mohacsi ◽  
...  

2012 ◽  
Vol 44 (7) ◽  
pp. 2007-2012 ◽  
Author(s):  
G. Brancaccio ◽  
S. Filippelli ◽  
G. Michielon ◽  
R. Iacobelli ◽  
S. Alfieri ◽  
...  

2017 ◽  
Vol 9 ◽  
pp. 117906521771421 ◽  
Author(s):  
Gabriel A Hernandez ◽  
Jonatan D Nunez Breton ◽  
Sandra V Chaparro

Advances in mechanical circulatory support devices provided the technology to develop long-term, implantable left ventricular assist devices as bridge to transplant, destination therapy, and in a lesser group of patients, as bridge to recovery. Despite the benefits from this innovative therapy, with their increased use, many complications have been encountered, one of the most common being infections. With the driveline acting as a portal to the exterior environment, an infection involving this structure is the most frequent one. Because patients with destination therapy are expected to receive circulatory support for a longer period of time, we will focus this review on the risk factors, prevention, and treatment options for driveline infections.


Sign in / Sign up

Export Citation Format

Share Document